What Multimin 90 Treats: Main Uses and Benefits

Multimin 90 is a targeted nutritional intervention that is applied in addressing specific clinical and subclinical deficiencies in four key trace elements, managing functional impairments that stem from these shortages rather than infectious or structural causes. Its core purpose is to provide a supplemental source of zinc, copper, manganese, and selenium in cattle.

Therapeutic Focus Areas

The medication is commonly used across conditions characterized by periods of heightened physiological stress, often applied during the critical pre-breeding and pre-calving phases, or when preparing animals for transport or vaccination. The core indications involve addressing symptomatic patterns linked to trace mineral deficits, including support for optimal reproductive performance (managing delayed heat cycles and assisting with conception rates) and support for immune function (supporting natural defenses against disease susceptibility). It is also relevant for easing physical deficiency indicators such as poor body condition, rough hair coat, and Nutritional Muscular Dystrophy (White Muscle Disease).

By managing these elemental shortages, the therapy provides support that helps ease the overall symptom burden and may assist with maintaining functional stability during crucial physiological transitions.

---

Quick Fact: Support for Functional Strain Multimin 90 is applied in scenarios where temporary physiological imbalance or nutritional insufficiency interferes with foundational processes, supporting general well-being during symptomatic phases.

Regulatory References

1. DailyMed Labeling from the National Library of Medicine

Who Can and Cannot Use Multimin 90?

This section outlines the officially documented eligibility and non-eligibility for Multimin 90, based strictly on government regulatory labeling for this veterinary product.

---

Eligibility Scope

Classification	Population/Condition	Regulatory Status
Approved Population	Cattle (Beef and Dairy)	Allowed
Use Restricted	Pregnant Cows/Heifers (First Trimester)	Not Recommended/Safety Not Established
Contraindicated	Concurrent Injectable Selenium/Copper or Boluses	Must Not Be Used
Contraindicated	Known Hypersensitivity to ingredients	Must Not Be Used
Age Restriction	Beef Calves under 2 months, All Dairy/Pre-Ruminant Calves	Not Established/Not for Use
Clinical Restriction	Emaciated Cattle (defined by low Body Condition Score)	Not for Use

---

Official Eligibility Summary

The eligibility profile strictly limits use to cattle only. The product is formally contraindicated in any animal receiving concurrent injectable selenium or copper supplements or mineral boluses, due to toxicity risk. Safety and effectiveness have not been established for use in young calves, specifically beef calves under two months of age or any pre-ruminant dairy calf. Additionally, use is restricted in pregnant animals during the first trimester and is not for use in emaciated cattle. These rules define the specific populations permitted to use this medicine under labeled conditions.

Interactions with Other Medicines and Products

The official regulatory profile for Multimin 90 (zinc, copper, manganese, and selenium injectable solution) focuses on the risk of additive elemental toxicity rather than pharmacokinetic interactions.

Documented Interaction Restrictions

The U.S. Food and Drug Administration (FDA) and other regulatory bodies document restrictions based on the potential for overdose when combining Multimin 90 with other sources of its active ingredients.

Interaction Type	Officially Documented Restriction
Pharmacodynamic Reinforcement	Do not use concurrently with other injectable selenium and copper products, or selenium or copper boluses.
Supplementation Risk	Do not administer additional zinc, copper, manganese, or selenium products at the same time.
Dietary Risk	Caution is required if the animal has excessive dietary intake of copper and selenium, which increases the overall toxicity risk.

Population and Condition-Specific Cautions

Specific animal health conditions are noted in the regulatory documents as increasing the risk associated with the mineral load, which is classified as an interaction-related constraint.

• Liver Impairment: The product is contraindicated in animals with pre-existing liver disease or fascioliasis (liver fluke infection), as these conditions heighten the risk of copper or selenium toxicity.
• Unestablished Safety: For specific species, such as deer, the product should not be given concurrently with other veterinary treatments (e.g., vaccines or anthelmintics) because co-administration safety has not been established in the label.

The mechanism of Multimin 90 is based on the rapid pharmacodynamic correction of trace element deficiencies by providing essential cofactors to restore specific enzyme functions. This cofactor provision resolves enzyme functional limitations, restoring cellular and metabolic capacity within several key physiological systems.

️ Restoration of the Cellular Antioxidant Defense System

This domain covers the critical roles of Selenium, Zinc, Copper, and Manganese as cofactors for the Glutathione Peroxidase ( GPx) and Superoxide Dismutase ( SOD) enzyme families. The simultaneous activation of these enzymes facilitates the scavenging of Reactive Oxygen Species ( ROS), leading to a restored state of cellular redox homeostasis and reduction in lipid peroxidation events.

Support for Energy Production and Metabolic Integrity

This mechanism focuses on the provision of Copper and Manganese to complete the structure of enzymes crucial for cellular bioenergetics, such as Cytochrome C Oxidase ( COX) and Pyruvate Carboxylase. Restoration of COX function enables efficient mitochondrial respiration and ATP synthesis, facilitating the energy currency necessary for cellular proliferation, leukocyte function, and other metabolically demanding processes.

Synergistic Facilitation of Tissue Structure and Immune Function

This final domain encompasses Zinc's role as a cofactor for Zinc finger Transcription Factors and Copper's role in activating Lysyl Oxidase ( LOX). This synergy supports gene expression and rapid proliferation to maintain immune cell functional integrity, while simultaneously ensuring the cross-linking of collagen and elastin for preservation of connective tissue integrity.

How to Use Multimin 90

Multimin 90 is administered exclusively as a single subcutaneous injection according to a protocol that is strictly dependent on the animal's weight and age class. The product is not intended for continuous or routine supplementation but is utilized as a single, intermittent dose based on management needs, with a mandatory minimum interval of 30 days before any subsequent administration can be considered.

---

Administration Requirements

All administration procedures are specified to ensure correct application:

• Route and Site: The product must be injected only subcutaneously (under the loose skin). The specific site for administration is the middle of the side of the neck.
• Dose Calculation: The volume of the dose is calculated based on accurate body weight, using one of three formulas:

Animal Population	Dosing Regimen (Volume per Weight)
Cattle up to 1 year	1 mL per 100 lb bodyweight
Cattle from 1–2 years	1 mL per 150 lb bodyweight
Cattle over 2 years	1 mL per 200 lb bodyweight

• Volume Constraints: A maximum of 7 mL of the solution may be administered per single injection site. If the calculated dose exceeds this limit, the volume must be divided and administered into separate sites with a minimum separation of 4 inches between them.

---

Handling the Vial

Specific in-use constraints must be observed after the sterile vial is initially punctured. The product remaining in the vial must be used within 28 days of the first puncture. Additionally, the vial is designed to withstand a maximum of 15 punctures to maintain integrity.

Multimin 90: Recent Clinical Evidence

The formulation known as Multimin 90 is an injectable trace mineral supplement containing four essential elements: zinc, copper, manganese, and selenium. Clinical studies have primarily examined its role as a supplementary source of these minerals in cattle populations, focusing on immune function and reproductive performance.

---

Research Scope and Study Design

Research has explored the effects of administering the trace mineral combination, often concurrent with vaccination protocols, across different age groups and mineral statuses (e.g., mineral-adequate vs. marginal). Trials have typically employed randomized, controlled designs, comparing the treatment group to a control group receiving a saline injection or a standard oral mineral supplement. Outcome measures frequently include:

• Immune Markers: Antibody titers, neutrophil function, and antioxidant enzyme activity (e.g., glutathione peroxidase).
• Reproductive Metrics: Artificial insemination conception rates and overall pregnancy rates.
• Health Outcomes: Incidence of disease, such as scours or bovine respiratory disease (BRD).

---

Overview of Study Findings

Findings regarding the use of the trace mineral blend are varied, reflecting differences in study population, baseline mineral status, and timing of administration.

Trace Mineral Status: Studies consistently reported increases in liver and serum concentrations of the injected minerals (zinc, copper, and selenium) following administration, though these effects were sometimes short-lived.

Immune Response:

Area of Investigation	Observation in Research
Vaccine Response	Administration concurrent with certain vaccines was associated with enhanced antibody titers against specific viral and bacterial antigens.
Cellular Function	Research noted changes in white blood cell function (e.g., neutrophil phagocytosis) and increased levels of antioxidant enzymes in some treated groups.

Reproductive Performance: In trials involving heifers or cows with adequate baseline trace mineral status, administration of the injectable supplement did not show a significant difference in overall pregnancy rates or artificial insemination conception rates when compared to controls. However, some research has suggested a tendency toward increased conception rates in certain protocols or in animals with marginal status.

Health and Growth: Some studies have reported reductions in the incidence of certain diseases, such as diarrhea (scours) in young calves, but many studies did not observe a difference in growth performance or overall weight gain.

Key Studies & References

1. The Effects of Injectable Trace Mineral Supplements in Donor Cows at the Initiation of a Superovulation Protocol on Embryo Production and Pregnancy Rate in Recipient Females
2. MULTIMIN 90- zinc oxide, manganese carbonate, sodium selenite, copper carbonate injection, solution (Full Prescribing Information/Label)

How to Store and Dispose of Multimin 90?

Regulatory requirements define specific conditions for storing and handling Multimin 90 to maintain its stability and integrity. The product must be stored at controlled room temperature, specifically between 15 C and 30 C (59 F and 86 F). It is essential to protect the product from light and freezing conditions.

Stability and Handling

Condition	Requirement
Temperature Range	15 C to 30 C (59 F to 86 F)
Protection	Protect from light and freezing.
In-Use Period	Use within 28 days of the first puncture.
Needle Constraint	Discard immediately after use if a large bore (greater than 16 gauge) needle is used.
Access	Keep out of reach of children.

Disposal

Dispose of the product and its associated waste according to local, state, and national regulations. This measure prevents environmental contamination.